USPTO serial 79200172
GLYCOMAX
Reviewed by CopyMark Law Group
Reg. 5515976Status 709
- Filing date
- Status date
- Registration date
- Jul 17, 2018
- Examiner
- NADELMAN, ANDREA KOYNER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GLYCOMAX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey H. Greger
Jeffrey H. Greger Hauptman Ham, LLP2318 Mill RoadSuite 1400Alexandria, VA 22314Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances, namely, skincare preparations and substances; pharmaceutical preparations derived from dairy sources for skin care and the treatment of eczema, psoriasis and other skin conditions; pharmaceutical preparations for the therapeutic treatment of diabetes; pharmaceutical preparations for skin care and pharmaceutical preparations for application to the skin for skin care, the treatment of eczema, psoriasis and other skin conditions; pharmaceutical preparations for the treatment of dermatitis; pharmaceutical preparations for boosting the immune system; pharmaceutical preparations and products for treatment of metabolic disorders; pharmaceutical preparations and substances whose primary purpose is to boost metabolism or fat burning; pharmaceutical agents for activating metabolism; dietary medical preparations for slimming purposes, including food supplements; dietary nutritional supplements not for medical purposes; dietetic substances, namely, dietetic foods adapted for medical use, including dietetic substances for use in weight control; dietetic foodstuffs for medical use in the form of prepared meals, namely, dietetic foods adapted for medical use; dietetic beverages adapted for medical purposes; dietetic additives for food, namely, meal replacements in the nature of powdered nutrition and protein supplements; meal supplements in the nature of dietary supplements and other formulated powdered preparations in the nature of glucose for use as an additive to foods for medical purposes; protein for dietetic purposes, namely, protein supplements; energy drinks in the nature of dietary supplemental drinks and energy drinks that are adapted for medical purposes, namely, dietary supplemental drinks; medicated preparations for use as additives for food for human consumption, namely, vitamin preparations for use as a supplement for dietary supplements and infant formula; foods for persons having complex metabolic disorders, namely, meal replacements in the nature of meal replacement bars adapted for medical use, meal supplements in the nature of nutritional supplement meal replacement bars for boosting energy, and other formulated powdered preparations, namely, powdered dietary supplements; foodstuffs for use in the dietary management of obesity, namely, special dietary foods, beverages and meal replacements in the nature of dietetic foods, namely, pasta adapted for medical use, meal replacement bars for weight loss purposes and meal replacement beverages adapted for medical use; health food supplements for persons with special dietary requirements; dried milk products for babies, namely, dried milk powder for babies; milk foods for babies; human milk oligosaccharide dietary supplements; human milk oligosaccharide compounds, namely, milk sugar for medical purposes; human milk oligosaccharide additives for use as nutritional supplements in connection with pharmaceuticals and infant formula; human milk oligosaccharide additives for use as a dietary or nutritional supplement; human milk oligosaccharide compounds, namely, milk sugar for medical use; health food supplements and mineral supplements, namely, mineral supplements for foodstuffs for human consumption; medicated mineral drinks, namely, medicated mineral spring waters; nutritional supplements, namely, nutritional supplements containing nut and fish oils; nutritional meal replacement powders in the nature of meal replacement powdered drink mixes adapted for medical use; nutritional meal replacements, namely, nutritional meal replacement bars, milkshakes and other powdered preparations adapted for medical use for individuals preparing for or undergoing medical treatments; non-carbohydrate dietary supplements other than for medical use; powdered dietary food concentrates in the nature of dietary supplement drink mixes; powdered dietary food concentrates in the nature of weight management supplements for use in weight reduction programmes for medical purposes; preparations for use as additives to food for consumption, namely, minerals and vitamin supplements; protein preparations in the nature of protein supplements for use as additives to foodstuffs for human consumption; protein based food preparations, being dietetic protein supplements and nutritional additives that are not for medical purposes in the nature of protein dietary supplements; slimming aids for medical use, namely, weight management products in the nature of dietary nutritional supplements; slimming preparations for medical use, namely, meal replacement shakes for weight loss purposes; slimming products for medical use, namely, stimulatory medications for use in weight reduction programmes; vitamins and vitamin supplements; none of the foregoing goods including cell lines, antibodies or proteins for pharmaceutical use | SECTION 71 - CANCELLED | — |
| 029 | Dairy produce and dairy products, namely, dairy-based beverages, dairy-based powders for making dairy-based food beverages and shake and dairy-based spreads; milk products excluding ice cream, ice milk and frozen yoghurt; milk; milk powder other than for babies; milk protein and milk protein products; milk powder replacers in the nature of milk powder; preparations for making milk based beverages in the nature of powdered milk; prepared meals consisting primarily of meat, fruit or vegetables | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Probiotec Limited
- Other trademarks owned by Probiotec Limited
- Other trademarks owned by Probiotec Limited
- Other trademarks in Class 005
- Other trademarks in Class 029
- Similar marks named GLYCOMAX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 21, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 21, 2026 | INPC | INVALIDATION PROCESSED | — |
| Sep 30, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 31, 2025 | C71T | CANCELLED SECTION 71 | — |
| Jul 17, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 16, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 30, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 30, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 17, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 17, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 29, 2018 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 14, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 14, 2018 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 10, 2018 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| May 16, 2018 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| May 15, 2018 | APET | ASSIGNED TO PETITION STAFF | — |
| Apr 27, 2018 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Feb 22, 2018 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 30, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 30, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 26, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 10, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 10, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 10, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 18, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 18, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 18, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 18, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 18, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 7, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 20, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 20, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 20, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 31, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 31, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 31, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 18, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 25, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 25, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 20, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 19, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 13, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 13, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 12, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |